SANJIVIN

Sanjivani Paranteral Ltd

Pharmaceuticals

A research-based pharmaceutical company engaged in the development and manufacturing of parenteral formulations and injectable medicines. Established in 1994, the company serves both domestic and international markets across multiple therapeutic areas including oncology, cardiology, infectious diseases, and critical care. Its export-oriented business model distinguishes it as a significant player in the global pharmaceutical supply chain, maintaining compliance with stringent international regulatory and quality standards.

Investors holding Sanjivani Paranteral Ltd

Ashish Kacholia

Investor

3.01%